ScholarMate
English简体中文繁體中文
客服熱線:400-1616-289
登入註冊
期刊論文

Metabolomic analysis of gut metabolites in patients with colorectal cancer: Association with disease development and outcome

Xie, Zhufu; Zhu, Rui; Huang, Xiaoying; Yao, Fei; Jin, Shu; Huang, Qiyou; Wang, Dequan; Li, Huan; Wang, Qiang; Long, Hui*; Wu, Qingming*wuhan univ sci & technol; first hosp wuhan; china three gorges univ; hubei univ med; 2
Oncology Letters2023-8DOI: 10.3892/ol.2023.13944
9閱讀
引用收藏
分享

摘要

Colorectal cancer (CRC) is one of the leading global malignancies with low 5-year survival and high mortality rates. Despite extensive research, the precise role of gut metabolites in CRC development and clinical outcomes remains unclear, while its elucidation may aid the development of improved clinical diagnosis and treatment options. In the present study, targeted metabolomic analysis was conducted on fecal samples from 35 patients with CRC, 37 patients with colorectal adenoma and 30 healthy controls (HC) to identify metabolite biomarkers. Using orthogonal partial least squares discriminant analysis, metabolomic features distinguishing the three groups were identified. Receiver operating characteristic (ROC) curve analysis was used to assess diagnostic utility for distinguishing CRC from HC. The association of gut metabolites with survival in patients with CRC was also analyzed by comparing short-term survivors (STS) and long-term survivors (LTS), and the prognostic ability of metabolites was predicted using Cox regression and Kaplan-Meier analysis. The results of the current study showed that the enriched pathways in CRC included 'caffeine metabolism', 'thiamine metabolism', 'phenylalanine, tyrosine and tryptophan biosynthesis' and 'phenylalanine metabolism'. ROC analysis found that 9,10-dihydroxy-12-octadecenoic acid, cholesterol ester (18:2) and lipoxinA4 distinguished CRC from HC. Joint quantification of these three metabolites resulted in an area under the ROC curve of 0.969 in the diagnosis of CRC. The analysis of the current study also showed that the expression of metabolites involved in 'sphingolipid metabolism' was mainly dysregulated in LTS and STS, while N-acetylmannosamine and 2,5-dihydroxybenzaldehyde were associated with better overall survival. In conclusion, the present study provided preliminary insight into the metabolic changes associated with CRC and may have important implications for the development of future diagnostic and treatment strategies.

學科與關鍵詞

關鍵詞
colorectal cancergut metaboliteprognosismetabolomicsoverall survival
相關
載入中…

文獻載入失敗,請重試

重試

發表資訊

論文狀態
公開發表
期刊
Oncology Letters
發表日期
2023-08
卷期
第 26 卷, 第 2 期
頁碼
358
DOI
10.3892/ol.2023.13944
語言
ENGLISH
成果收錄
SCIE

作者

  • X

    Xie, Zhufu (第一作者)

    wuhan univ sci & technol

  • Z

    Zhu, Rui

    wuhan univ sci & technol

查看全部 11 位作者收起作者
  • H

    Huang, Xiaoying

    first hosp wuhan

  • Y

    Yao, Fei

    china three gorges univ

  • J

    Jin, Shu

    hubei univ med

  • H

    Huang, Qiyou

    wuhan univ sci & technol

  • W

    Wang, Dequan

    wuhan univ sci & technol

  • L

    Li, Huan

    wuhan univ sci & technol

  • W

    Wang, Qiang

    wuhan univ sci & technol

  • L

    Long, Hui (通訊)

    wuhan univ sci & technol

  • W

    Wu, Qingming (通訊)

    2 · wuhan univ sci & technol

登入解鎖更多功能

  • 收藏這篇,隨時在「我的 · 收藏」找回
  • 認領你的成果,生成推廣素材
  • 關注作者獲取最新成果
  • 加入項目組、協同寫作
註冊 / 登入

產品服務

  • 科研之友
  • 創新城
  • 科創雲

服務支援

  • 幫助中心
  • 隱私政策
  • 服務條款

聯絡方式

線上客服:【】
客服熱線:400-1616-289
電子郵件:support@scholarmate.com

關注或下載科研之友

微信 QR Code
微信公眾號
客戶端下載 QR Code
下載客戶端
科研成果科研人員科研機構科研動態愛瑞思軟件

©2026 深圳市科研之友网络服务有限公司

公安備案圖示粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417